Private Advisor Group’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Private Advisor Group’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-12,400	Closed	-$1K	–	1633
2018 Q4	$1K	Sell	12,400 -3,135	-20%	-$2.06K	﹤0.01%	1352
2018 Q3	$26K	Buy	+15,535	New	+$27.8K	﹤0.01%	1576
2017 Q3	–	Sell	-10,065	Closed	-$45K	–	1519
2017 Q2	$45K	Buy	+10,065	New	+$41.5K	﹤0.01%	1357

Other funds holding SGYP

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Private Advisor Group's SGYP Position: Q1 2019 in Review

Private Advisor Group sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2019, closing a stake of 12,400 shares — an estimated $1K sold.

Private Advisor Group first reported a position in SGYP in Q2 2017 and held it in 3 quarters. The position peaked at $45K in Q2 2017. 12 funds tracked by Wall St. Rank hold SGYP as of Q1 2019.

Private Advisor Group reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2019 after selling out during the quarter.
Private Advisor Group sold 12,400 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2019, an estimated $1K.
Private Advisor Group first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2017 and held it in 3 quarters.
Private Advisor Group's Synergy Pharmaceuticals, Inc Common Stock position peaked at $45K in Q2 2017.
12 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2019.

Based on Private Advisor Group's 13F filing for Q1 2019, filed 13 May 2019.